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Predictive Factors for Adverse Outcome of Pedal Bypasses
F. Biancari, A. Alba¨ck, I. Kantonen, M. Luther* and M. Lepa¨ntalo†
Division of Vascular Surgery, Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland
Objective: to identify the risk factors affecting the outcome of bypass grafts to the foot arteries.
Design: longitudinal observational study from a single institution.
Materials and methods: one-hundred and sixty-five infrainguinal bypasses to the foot arteries were performed in 162
legs of 149 patients with critical leg ischaemia.
Results: at 1-month, 1-year, 2-year and 3-year follow-up, the primary patency rates were 74%, 43%, 38% and 34%,
the secondary patency rates were 82%, 50%, 47% and 41%, the leg salvage rates were 88%, 66%, 66% and 60%,
survival rates were 95%, 76%, 69% and 55%, whereas 82%, 53%, 49% and 36% of patients were alive with salvaged
leg, respectively. Low preoperative plasma concentrations of C-reactive protein (CRP) and short grafts with more distal
arterial inflow had a better outcome. Better primary and secondary patency rates were also achieved by experienced
surgeons and by the use of in situ saphenous vein grafts. Pedal run-off scoring did not have any impact on the outcome
of pedal bypasses.
Conclusions: short pedal bypasses using in situ saphenous vein technique, done by an experienced surgeon, have the
best outcome. Revascularisation to the foot arteries may carry a poor outcome in patients with elevated preoperative CRP
concentration.
Key Words: Pedal bypass; Critical limb ischaemia; Adverse factors; C-reactive protein; Inflow artery; In situ saphenous
vein; Experience.
Introduction with chronic critical limb ischaemia (CLI) (Table 2).
Patients in whom an adjuvant arterovenous fistula
During the last two decades, bypass grafts to the was added to the pedal bypass graft were excluded
foot arteries have been shown to be effective in the from the present study. Revascularisation of the isch-
management of patients with chronic critical leg isch- aemic foot was mostly performed prior to minor am-
aemia (CLI) and severely diseased crural arteries. putations, which usually were performed on the third
Nowadays, such procedures comprise 20% or more of postoperative day after bypass operation. There were
infrainguinal reconstructions in many institutions1 and two vascular surgeons with a high throughput of distal
several series have achieved impressive results in bypass surgery and 15 surgeons with less experience
terms of patency and leg salvage (Table 1). However, in pedal bypass surgery or in the later phase of their
the results of centres of excellence are not necessarily vascular training.
achievable in population-based series or in training According to the European Working Group on Crit-
units.26 ical Leg Ischaemia,27 an ankle systolic pressure of
This paper reports the results of our experience in Z50 mmHg or a toe systolic pressure of Z30 mmHg
165 pedal bypasses performed during a 67-month were assumed as a diagnostic criterion for CLI. Media-period and an analysis of the risk factors which affected
sclerosis prevented accurate preoperative meas-the outcome of these bypasses.
urements of the ankle/brachial index (ABI) in 39 cases
(24%) and we were not able to measure the toe systolicMaterial and Methods
pressure preoperatively in 67 cases (41%). These
patients had ankle PVR amplitudes all below 5 mm.Between 1991 and 1996, we performed 165 bypass
In these patients, the diagnosis of chronic critical legprocedures to pedal arteries in 162 legs of 149 patients
ischaemia was defined by the clinical symptoms and
signs. Twenty-seven patients had persistent rest pain* Present address: Department of Surgery, Vaasa Central Hospital,
Vaasa, Finland. only (16%), whereas foot ulceration or gangrene was
† Please address all correspondence to: M. Lepa¨ntalo, Division of present in 138 legs (84%). We were able to reviewVascular Surgery, Department of Surgery, Meilahti Hospital, Hel-
sinki University Central Hospital, PO Box 262, 00029 HYKS, Finland. the preoperative serum concentrations of C-reactive
1078–5884/99/080138+06 $12.00/0 Ó 1999 W.B. Saunders Company Ltd.
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Table 2. Patient data and preoperative risk factors.
No. of patients/procedures 149/165
Sex M/F 68/81
Mean age (range) 72.3 (35–96)
Rest pain 27 (16%)
Foot ulcer 106 (64%)
Foot gangrene 32 (19%)
Mean serum level of CRP (range) 20 (1–196) mg/l*
Diabetes 115 (70%)
Current smoking 19 (12%)
Hypertension 59 (36%)
Coronary heart disease 87 (53%)
Cerebrovascular disease 18 (11%)
Chronic pulmonary disease 14 (9%)
Uraemic patients not on dialysis 19 (12%)
Uraemic patients on dialysis 10 (6%)
Previous vascular surgery 72 (44%)
Median preoperative ankle/brachial index 0.46 (0.15–1.00)
(range)
Median preoperative toe pressure (range) 22 (0–97)
Median pedal run-off score (range) 5.5 (1–10)
Inflow artery
Common iliac artery 1 (1%)
External iliac artery 3 (2%)
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Common femoral artery 80 (48%)
Superficial femoral artery 31 (19%) Fig. 1. Leg salvage after pedal bypass procedures using distal
Above-knee popliteal artery 18 (11%) (—-—) and proximal (––––) inflow arteries.
Below-knee popliteal artery 27 (16%)
Anterior tibial artery 2 (1%)
Prosthetic graft 3 (2%)
Outflow artery
DPA or PTA 156 (95%) All patients underwent preoperative selective angio-
Plantar arteries 9 (5%) graphy to evaluate the extent of arterial disease andReconstruction material
to choose the appropriate inflow and outflow vessel.Autogenous saphenous vein in situ 82 (50%)
Various combinations of autogenous vein 63 (38%) Pedal arteries were chosen as outflow vessels when-
grafts ever angiography revealed occlusion of all cruralCombined vein/PTFE 19 (12%)
vessels or these were not in continuity with the footPTFE 1 (1%)
Operations done by experienced vascular 113 (68%) arteries, even if the pedal arch was not angio-
surgeons graphically visualised. The posterior tibial artery wasOperations done by less experienced vascular 52 (32%)
considered pedal only below the malleolar level.surgeons
In 142 patients, the preoperative angiographic find-
* normal values: 1–10 mg/l; DPA: dorsalis pedis artery; PTA: pos- ings of pedal run-off on lateral foot X-rays were gradedterior tibial artery.
according to the Ad Hoc classification28 which assigns
a value of zero for a completely patent arch, 1.5
for partial occlusion and 3 when little or no arch isTable 3. Postoperative complications.
visualised.
Complications No. (%) Patient details, preoperative risk factors and op-
erative details are listed in Table 2. The reconstructiveGraft occlusion 41 (25)
Wound edge necrosis 35 (21) operation was conducted under combined spinal and
Deep infection 11 (7) epidural anaesthesia and was performed in 113 in-
Haematoma 15 (9) stances by an experienced vascular surgeon (ML andRenal 9 (5)
Cardiac 17 (10) ML) and in 52 instances by an inexperienced vascular
Cerebrovascular 1 (1) surgeon or a vascular surgeon in training. Bilateral
Respiratory 11 (7) pedal bypass procedures were performed in 12Venous thombosis 1 (1)
Multi-organ complications 2 (1) patients (8%). In 9 cases (5%), occlusion of a previously
done femoropopliteal or femorocrural bypass graft
imposed the indication for a bypass to the foot arteries,
and in 14 patients (8%) pedal bypass grafting was doneprotein (CRP) in 113 patients. Specimens for culture
were taken perioperatively in 75 cases with tissue in emergency conditions. Femoral endarterectomy and
profundoplasty was required in 12 patients to improveloss, to guide the antibiotic therapy. Cultures from 63
ischaemic lesions were either old or not available. the inflow. Microvascular muscle-flap transfer for
Eur J Vasc Endovasc Surg Vol 18, August 1999
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Table 4. Number of pedal bypasses per year carried out from 1991 to 1997.
Year No. of infrainguinal No. of pedal bypasses (% among Immediate failures
reconstructions all infrainguinal reconstructions) of pedal bypasses
1991 72 1 (0.9%) 0
1992 135 15 (11.1%) 2 (13.3%)
1993 150 33 (22%) 8 (24.2%)
1994 179 36 (20.1%) 11 (30.6%)
1995 250 51 (20.4%) 14 (27.5%)
1996 254 29 (11.4%) 6 (20.7%)
1997* 171 29 (16.9%) 3 (10.3%)
* 10 months’ data: the year 1997 is included in the table (but not in the study) to illustrate the change in
treatment strategy and immediate results.
major tissue loss were added to the bypass graft in 7 82%, 53%, 49% and 36% of patients were alive and
with salvaged leg, at the same intervals.patients to cover a major tissue defect.
The patency of the reconstructed vessels was as- Multivariate analysis (MA) showed that a high pre-
operative concentration of CRP had a significant ad-sessed every 3 months during the first year and every
6 months thereafter. Graft patency was determined by verse impact on long-term primary patency (p=0.03),
secondary patency (p=0.002), leg salvage (p=0.007)clinical examination, ABI measurements and duplex
Doppler and angiography, whenever symptoms re- rates, and success defined by patients alive, with
salvaged leg (p=0.004). We have calculated thatcurred or there was a suspicion of threatening graft-
failure. A postoperative ABI increase of 0.15 or more patients undergoing a pedal bypass procedure with a
serum level of CRP above or equal to 100 mg/l haveover preoperative values has been adopted as the
measure of haemodynamic success of the procedure. about a two-fold risk for limb loss at one year (176%).
An association between preoperative CRP con-Data were statistically analysed with the use of a
microcomputer database (SPSS for Windows 7.0, SSPS centrations and Pseudomonas aeruginosa (p=0.02),
Enterococcus faecalis (p=0.04) and StenotrophomonasInc., 444 North Michigan Avenue, Chicago, IL 60611,
U.S.A.). The Kaplan–Meier method was used to es- maltophilia (p=0.008) infections was also observed.
Short pedal bypasses with distal inflow vessels, i.e.timate graft patency, limb salvage, survival and success
defined as patient alive and with salvaged leg. The popliteal and tibial arteries, had significantly better
primary patency (MA: p=0.03), secondary patencyCox regression model and the likelihood-ratio test,
with the help of backward selection, were used to (MA: p=0.006) and leg salvage (MA: p=0.04) (Fig. 1)
rates than long bypasses with proximal inflow, i.e.estimate the impact of variables on the clinical out-
come. The Chi-squared and Fisher’s exact tests were iliac and femoral arteries as well as prosthetic grafts
at the groin. There were marked annual variations inused to analyse categorical data and the Mann–
Whitney test was used to analyse continuous data. the number of grafts and immediate failure rate during
the study years (Table 4). Better primary patency and
secondary patency rates were achieved both by ex-
perienced surgeons (MA: p=0.03 and p=0.002, re-
Results spectively) and by the use of in situ saphenous vein
grafts (MA: p=0.05 and p=0.02, respectively). The
Immediate haemodynamic success was achieved in run-off score did not show impact on the outcome of
97 cases (81%) among 119 patients with available pedal grafts.
preoperative and postoperative ABI values. Eight
patients (5%) were treated in the intensive care unit
for more than 5 days and 9 patients (5%) died during
the in-hospital stay. A high rate of cardiac com- Discussion
plications (10%) was observed (Table 3).
The primary patency rates at 1-month, 1-year, 2- Since it has been shown that unreconstructed CLI
has a poor outcome,29 an aggressive revascularisationyear and 3-year follow-up were 74%, 43%, 38% and
34%, while secondary patency rates at the same in- policy has been widely adopted, as it is more cost-
effective and may result in a better quality of lifetervals were 82%, 50%, 47% and 41%, respectively.
The limb salvage rates were 88%, 66%, 66% and 60%, than amputation, even in patients more than 80 years
old.30–33 Long-term graft patency and limb salvagesurvival rates were 95%, 76%, 69% and 55%, whereas
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results after pedal bypass grafts have been reported derangement and systemic complications. In our
series, the corresponding correlation between CRP andto approach 80–90% in most of published series (Table
survival rates was somewhat lower. However, this1) suggesting the feasibility of such treatment. How-
marker was found to have great impact on the successever, outcomes other than limb salvage and graft
defined as patient alive and with legs, an observationpatency may also have importance in the evaluation
which suggests its use as a potentially helpful means inof the results of pedal bypass.1 In fact, most of the
identifying patients with both salvageable extremitieslarge series failed to report long-term survival
and life. Furthermore, local de´bridement, or minordata3,6–9,12,16,19,20,22,24,25 and none mentioned the number
amputation in combination with strong antibiotic ther-of patients alive and with their legs after re-
apy should perhaps be undertaken more often priorvascularisation.26 It is our belief that these two para-
to pedal bypass rather than our current policy whichmeters are of importance. They should also strongly
is to bypass first and amputate later.influence the decision to reconstruct or not to re-
In conclusion, CRP may provide a preoperativeconstruct. Furthermore, most of the studies did not
method for a better selection of patients undergoingexplore those factors potentially responsible for limb
revascularisation to the foot arteries as well as theand/or life loss which may restrict the indications for
timing of local and bypass surgery. Short pedal by-pedal bypass surgery.
passes performed by an experienced surgeon using anIn an effort to save as many legs as possible we
in situ saphenous-vein technique improves the results.used suboptimal techniques other than in situ vein
grafting in no less than 50% of the legs. These attempts
were characterised by the high number and high fail-
ure rate of pedal bypasses during the years 1993–1995.
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